The effective management of Addiction: An Italian Experts’ Opinion using a Nominal Group Technique (NGT) Approach
Simone De Persis, Alessandro Pallucchini, Monica Baiano, Arianna Camporese, Rossella Garofano, Francesco Mancuso, Ilenia Zanoni, Marialuisa Grech, and Salvatore de Fazio
Psychometric evaluation of two patients monitored for 12 weeks after switching from racemic methadone to levomethadone agonist therapy
Gabriele Pasquale De Luca, Gaia Anibaldi, Danilo Paolucci, Paola Motta, and Simone De Persis
Efficacy and safety of naldemedine in the long-term treatment of opioid-induced constipation in patients on methadone agonist therapy monitored for three consecutive months
Emanuele Corbucci, and Piero Pierucci
Beginning with buprenorphine depot: characteristics and experiences of the first patients in a French addictions centre.
Alice Deschenau, Amir Al Tabchi, Marie-Charlotte Noury, Léa Micheletti, Husen Ali-Diabacte, Elisa Vodislav, Nathalie Texier, Sarah Hervy, and Didier Touzeau
The effects of heroin on pregnant rats and the reproductive system of female offspring
Fatemeh Osanloo, Ramin Hajikhani, Gholamhassan Vaezi, and Maryam Bananej
Pet ownership, physical activity and mental health among people in opioid maintenance treatment: a prospective, observational study
Cornelia Haarr Hatlo, Thomas Clausen, Ashley Elizabeth Muller, and Gustavo Sugahara
Suicidal behaviour and its risk factors in patients with opioid use disorder
İpek Buse Güzelce, Bulent Kadri Gultekin, and Muhsin Koray Kılıç
Satisfaction of patients on methadone maintenance treatment with changing policies during the COVID-19 pandemic
Anat Sason, Marsha Weinstein, Miriam Adelson, Shaul Schreiber, and Einat Peles
The relationships among withdrawal symptoms and depression in IV injection and non-injection groups in a population of heroin users
Kunhua Lee, and Cheng Fang Yen
The Impact of Chronic Pain and Depression on Medication for Opioid Use Disorder Treatment: A Mixed-Methods Analysis
Corinne N. Kacmarek, Hannah C. Smith, Maxwell Kuehn, Melanie E. Bennett, Annabelle Belcher, Heather Fitzsimons, William Hall, Aaron Greenblatt, Lan Li, and Letitia Travaglini
Using genetic parameters to predict somatization in females with heroin dependence
Kadir Uludag, Hang Su, Haifeng Jiang, Jiang Du, Na Zhong, and Min Zhao
Invisible: An exploratory study of the impact of COVID-19 restrictions on people who use heroin
Daniela-Irina Stadniciuc, Marie-Claire Van Hout, Stephanie Kewley, and Georgina Mathlin
The severity of Heroin Use Disorder in patients at treatment entry and their therapeutic response to Opioid Agonist Treatment
Filippo Della Rocca, Francesco Lamanna, Lucia Massa, Giulia De Luca, Mario Miccoli, Icro Maremmani, and Angelo G. I. Maremmani
"Life feels better with the right medication". Results from a service user organization-led survey of opioid maintenance treatment patients in Norway
Gabrielle K. Welle-Strand, Marianne Pierron, Ida Kristine Olsen, Ronny Bjørnestad, and Rebecca McDonald
Maternal Buprenorphine split dosing
Cindy Flores, Usman Riaz, Peter Tenore, and Nazar Muhammad
Heroin addiction history, psychopathology and stress sensitivity in a sample of migrants to Italy
Manuel Glauco Carbone, Claudia Tagliarini, Filippo Della Rocca, Marina Ricci, Anna M. Lupi, Lucia Sarandrea, Angela Ceban, Pietro Casella, Icro Maremmani, and Angelo G. I. Maremmani
HCV-RNA viral load fingerstick assay to simplify screening and linkage to care of people who use drugs attending Italian addiction treatment centres: A pilot project
Sarah Vecchio, Claudio Leonardi, Luigi Bartoletti, Daniela Mussi, Roberta Gaudenzi, Eugenia Vernole, Duncan Hill, Matteo Pacini, and Lorenzo Somaini
Night eating syndrome, impulsivity, sleep disorder and craving in opioid use disorder patients in remission phase
Pınar Erdogan Turkmen, Ali Erdogan, and Burak Kulaksızoglu
Addressing methamphetamine use in opioid use disorder treatment: Clinical perspectives
Mustafa Danışman, Gamze Zengin İspir, and Kübra Sezer Katar
Group counselling can prolong the remission period in opioid use disorder patients after detoxification and enhance social support, self-efficacy and hopelessness levels in patients and their families in Turkey.
Belgin Varol, and Fatma Oz
A community-based tele medication-assisted treatment (TMAT) for delivery of methadone maintenance treatment (MMT) during the COVID-19 pandemic in India: A single-arm, prospective feasibility study
Roshan Bhad, Deepak MB, Vinit Patel, Jaswant Jangra, Ravindra Rao, and Pooja Shakya
Pattern of illicit drug use in Sri Lanka; A detailed analysis from a country of transient point for drug trafficking
Nuwan Darshana, Champa Wijesinghe, and Vijitha De Silva
Liver function and lead levels increase by oral and inhaled opium use in Iranian addiction treatment centres
Mohamad Ghaiedi, Zahra Barmoudeh, zahra daneshyar, Janmohamad Malekzadeh, and Sajad Hassanzadeh
Socio-demographic characteristics and patterns of substance use disorder in Montenegro
Ena Grbovic, and Bojana Miletic
Recruiting and Retaining Patients in Low Threshold Opioid Agonist Treatment: A Retrospective Cohort Study
Kathleen Henriksen, Jon-Aksel Jacobsen, Elliott Henriksen, Leni Gomes, Linda Elise Wüsthoff, Espen Ajo Arnevik, and Peter Krajci
The effect of intravenous heroin injection on gene expression in HIV-1 infected people
Ahmad Hosseinzadeh Adli, and Seyed Mohammad Jazayeri
Prevalence of psychiatric and physical comorbidities in patients diagnosed with opioid use disorder (OUD) in Lanarkshire, Scotland. 2018-2019: cross-sectional study
Hanan Khaled Ali Al-Shemali, Duncan Hill, Tatiana Chama Borges Luz, and Louise Evans
Raha syrup attenuates the severity of physical and psychological dependence and voluntary morphine consumption in morphine-withdrawn rats receiving the opium tincture maintenance treatment
Hajar Yazdani, Mahdi Zahedi-Khorasani, Ali Ghanbari, Ali Khaleghian, and Hossein Miladi-Gorji
The maintenance treatment with opium tincture and exercise normalize the electroencephalographic changes and reduce visual image-induced craving in opioid use disorder patients
Mahya Bavisi, Roshanak Tirdad, Raheb Ghorbani, Masoud Hajirasouli, Reza Khosrowabadi, and Hossein Miladi-Gorji
Effects of heroin and other illicit drug usage on family and social network in Sri Lanka. Evidence from a cross sectional study
Nuwan Darshana, Champa Wijesinghe, and Vijitha De Silva
Illicit drug use among Sri Lankan school-going adolescents: A Qualitative study
Amila Chandrasiri, Nuwan Darshana, Ishara Wanniaracchchi, Sajeewa De Silva, and Konara Somarathne
Mental well-being and illicit drug use related risk factors in Sri Lankan institutionalised male drug users
Nuwan Darshana, Champa Wijesinghe, and Vijitha De Silva
Determination of sexual functioning, quality of life levels, and healing factors of substance-abusing men who continue the rehabilitation program in Turkey
Melike Dişsiz
Association between religiosity/spirituality and opioid abuse: A systematic review
Alessandra Buja, Laura Montecchio, Daniele Vo, and Roberta Lo Bue
Amphetamine and amphetamine-like compounds, new psychoactive substances (NPS), and synthetic cathinones. State of the problem in Russia and Belarus
Tatyana V. Klimenko, Svetlana M. Shakhova, Alexander A. Kozlov, and Sergey A. Igumnov
The effect of the physician-nurse-social worker linkage rehabilitation model on the psychological status of MMT patients
Qiaofang Huang, Shanfang Su, Lian Duan, Junyi Lin, Caimei Zou, Shaojuan Wu, and Shichao Xu
Effect of changes in life-related factors on mood status and life quality of methadone maintenance therapy (MMT) patients after withdrawal from MMT
Penghui Cao, Qiaofang Huang, Nannan Pan, Huaxin Li, Daoyi Feng, and Ziyan Fang
Somatic and mental health among older patients in opioid agonist therapy: a cross-sectional geriatric assessment study
Lennart Niels Mayer-Eckardt, Ole Gnirss, Maximilian Meyer, Katharina Roser, Kenneth M. Dürsteler, and Marc Vogel
Micro-dosing with buprenorphine when switching from full agonists (methadone, SR-morphine) to buprenorphine treatment in opioid agonist-assisted treatment programmes in Slovenia
Miha Lavre, and Andrej Kastelic
Is the SCL90-based five-dimensional structure able to differentiate Heroin Use Disorder patients with low and high benzodiazepine dependence symptomatology?
Angelo G. I. Maremmani, Filippo Della Rocca, Silvia Bacciardi, Mario Miccoli, and Icro Maremmani
International perspectives on opioid use disorder and treatment: Results from an online convenience sample
Katrine Melby, Mehdi Farokhnia, Serenella Tolomeo, Roshan Bhad, Jørgen G. Bramnes, Alex Baldacchino, Ravindra Rao, Gomathinayagam Kandasami, Jenna L. Butner, Vicky Phan, Francina Fonseca, Parnian Rafei, Long Jiang, Georgios Tzeferakos, and Geert Dom
Extended-release subcutaneous buprenorphine. The 3rd therapeutic revolution
Marc Reisinger
Clinical characterisation of dual depression and association with bipolarity features
Margherita Barbuti, Jean-Michel Azorin, Jules Angst, Charles L. Bowden, Sergey Mosolov, Allan H. Young, Eduard Vieta, Giulio Perugi, and Icro Maremmani
Exploring Theory of Mind and Empathy Progression Alongside Cognitive Gains in Methadone Maintenance Treatment
Shlomit Zorani, and Einat Peles
Evaluation of the introduction of buprenorphine – naloxone oro-adhesive film formulation to patients in NHS Lanarkshire
Duncan R. B. Hill
Perinatal Injectable Opioid Agonist Therapy (iOAT) Treatment Experience: A Qualitative Study
Charissa Patricelli, Ruth Liu, Shanlea Gordon, Nicole Carter, Karly Stewart, Isabelle Gouin, Vanessa Paquette, Jeff Bone, and Karen Urbanoski
Sociodemographic and Clinical Factors of Dropout from Inpatient Detoxification Treatment in Patients with Opioid Use Disorders
Rahime Dicle Cetiner Akgul, Mine Ergelen, Selim Arpacıoglu, and Murat Yalcın
Hospital admissions for alcohol, opioids, cannabinoids and sedatives or hypnotics related intoxications among children, adolescents and young adults in Slovenia: the period before and after the start of the COVID-19 pandemic
Mercedes Lovrecic, Mateja Rok Simon, Ales Korosec, and Barbara Lovrecic
The estimated and actual prevalence of dementia among heroin addicts in opioid agonist treatment and comparison with general population, In Slovenia
Mercedes Lovrecic, Icro Maremmani, Manuel Glauco Carbone, and Barbara Lovrecic
Clinical characteristics of Substance Use Disorders elderly patients: a look at a Swiss psychogeriatric inpatient unit
Vincenza Spera, Alireza Moor, Manuel Glauco Carbone, and Icro Maremmani
Buprenorphine with and without Gabapentin and Clonidine in detoxification of 5-16 year-old children with Opioid Use Disorder: a randomised controlled trial
Mahin Eslami Shahrbabaki, Habibeh Ahmadipour, Atefeh Ahmadi, Mohammadamin Abdi, Zahrasadat Shiva, and Marjan Shamspour
The rise of the 'Opiate Rule' - A dismal parenthesis for Opioid Agonist Treatment in Sweden from 2010 to 2016
Bodil Monwell
The Opiate Rule - An inferior regulating of opioid agonist treatment in Sweden 2010-2016 and how was it handled in practice
Bodil Monwell
Remission Rates of Patients with Opioid Use Disorder Who Got Naltrexone Implantation: A Retrospective Study
Mustafa Danışman, Seyit Murat Aydın, Gamze Zengin İspir, Kübra Sezer Katar, and Mustafa Batuhan Kurtoğlu
Intervention on Dual Disorders: the role of qualitative evaluation for psychopathology observation and psychotherapy research on causation
Emanuela Atzori
Consumption Patterns and Relevant Habits of Patients on Methadone Maintenance Therapy in Tehran, Iran
Reyhaneh Mehrvar, Saeideh Soltani, and Ali Kheradmand
Medical Adjustment of Alcohol Use Disorder (AUD) with Opioids
Albrecht Ulmer
Need for opioid agonist therapy among opioid users of open drug scenes
Heike Zurhold, Silke Kuhn, Jens Reimer, and Uwe Verthein
Gambling prevalence in patients with dependence on different psychoactive substances
Zuzana Kamendy, Adam Kurilla, and Lubomir Okruhlica
Opioid agonist maintenance treatment in kyrgyzstan: Assessing patients’ changing medical and psychosocial needs over the course of treatment
Zhyldyz Bakirova, Ulla Pape, and Ingo Ilja Michels
Evaluating Substance-Related Dreams and Their Impact on The Treatment Process Through the Mechanism of Censorship in Dreams. A Pilot Study
Mustafa Danisman, Claudio Colace, Safak Yalcin Sahiner, and Hakki Polat
Investigating the Association Between Heroin Dose, Genetics, and Personality Disorders
Kadir Uludag, Hang Su, Haifeng Jiang, Jiang Du, Na Zhong, and Min Zhao
Alcohol Hallucinosis has its distinct entity, or is it a predisposing condition to Delirium Tremens or Major Psychotic Disorder?
Usman Riaz
High-risk behaviour for sexually transmitted diseases and bloodborne viral infections among Institutionalized Male Drug Addicts in Sri Lanka
Nuwan Darshana, Champa Wijesinghe, and Vijitha De Silva
Lifestyle changes during first COVID-19 lockdown: a survey in patients on opioid agonist therapy and medical students in Switzerland
Francesca Mosar, Ursula S. Spitzer, Maximilian Meyer, Elisa Guggisberg, Alyssa Lüthy, Marc Walter, Marc Vogel, and Kenneth M. Dürsteler
Quality of life among opioid use disorder patients on opioid agonist therapy in Vojvodina
Masa Comic, Dragana Ratkovic, Vladimir Knezevic, Aleksandra Dickov, Svetlana Ivanovic-Kovacevic, Olga Ivetic, Dusan Kuljancic, and Ksenija Kolundzija
Rapid transition from high-dose methadone to buprenorphine-naloxone and long-acting buprenorphine in a perinatal patient with Opioid Use Disorder: A case report
Sara Kreim, Shanlea Gordon, Nicole Carter, Melissa Dreyer, James Ketch, and Charissa J. Patricelli
